Literature DB >> 32839839

Efficacy of acupuncture for migraine prophylaxis: a trial sequential meta-analysis.

Shi-Qi Fan1, Song Jin2, Tai-Chun Tang2, Min Chen3, Hui Zheng4.   

Abstract

BACKGROUND: Acupuncture is commonly used for migraine prophylaxis; however, evidence of its efficacy was equivocal. AIM: We aimed to evaluated the efficacy of acupuncture in migraine prophylaxis and calculated the required information size (RIS) to determine whether further clinical studies are required.
METHODS: We searched Cochrane library, EMBASE and PubMed from inception to April 23th, 2020. Randomized trials that compared acupuncture with conventional drug therapy or sham acupuncture were included. The primary outcome was migraine episodes. Secondary outcomes were responder rate and adverse event.
RESULTS: Twenty studies (n = 3380) met the inclusion criteria. When it comes to migraine episodes, Acupuncture was superior over sham acupuncture [SMD = - 0.29, 95% CI (- 0.47 to - 0.11), P = 0.002] after treatment, while the difference between acupuncture and prophylactic drugs was not significant [SMD = - 0.21, 95% CI (- 0.42 to 0.00), P = 0.06].Both TSA graphs indicated that more RCTs are needed. As for responder rate, the results after treatment showed that acupuncture was statistically significantly better than sham acupuncture [RR 1.30, 95% CI (1.09-1.55), P = 0.003] as well as conventional drugs [RR 1.24, 95% CI (1.04-1.48), P = 0.01]. Both of their cumulative Z-curves intersected with the trial sequential monitoring boundaries favoring acupuncture. Compared to prophylactic medication, acupuncture can cause less adverse events [RR 0.34, 95% CI (0.14-0.81), P = 0.01].
CONCLUSION: Acupuncture can reduce migraine episodes compared to sham one and can be an alternative and safe prophylactic treatment for conventional drugs therapy, but it should be further verified through more RCTs. Available studies suggested acupuncture was superior to sham acupuncture and conventional drugs in terms of responder rate as verified by TSA.
© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Acupuncture; Conventional drug therapy; Migraine prophylaxis; Sham acupuncture

Mesh:

Year:  2020        PMID: 32839839     DOI: 10.1007/s00415-020-10178-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.

Authors:  H C Diener; J Matias-Guiu; E Hartung; V Pfaffenrath; H P Ludin; G Nappi; F De Beukelaar
Journal:  Cephalalgia       Date:  2002-04       Impact factor: 6.292

2.  Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial.

Authors:  C-P Yang; M-H Chang; P-E Liu; T-C Li; C-L Hsieh; K-L Hwang; H-H Chang
Journal:  Cephalalgia       Date:  2011-10-21       Impact factor: 6.292

3.  Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis.

Authors:  Jørn Wetterslev; Kristian Thorlund; Jesper Brok; Christian Gluud
Journal:  J Clin Epidemiol       Date:  2007-08-23       Impact factor: 6.437

4.  Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

Authors:  Kristian Thorlund; P J Devereaux; Jørn Wetterslev; Gordon Guyatt; John P A Ioannidis; Lehana Thabane; Lise-Lotte Gluud; Bodil Als-Nielsen; Christian Gluud
Journal:  Int J Epidemiol       Date:  2008-09-29       Impact factor: 7.196

Review 5.  Systematic Review of Episodic Migraine Prophylaxis: Efficacy of Conventional Treatments Used in Comparisons with Acupuncture.

Authors:  Kien V Trinh; Dion Diep; Kevin Jia Qi Chen
Journal:  Med Acupunct       Date:  2019-04-19

6.  Canadian Headache Society guideline for migraine prophylaxis.

Authors:  Tamara Pringsheim; W Jeptha Davenport; Gordon Mackie; Irene Worthington; Michel Aubé; Suzanne N Christie; Jonathan Gladstone; Werner J Becker
Journal:  Can J Neurol Sci       Date:  2012-03       Impact factor: 2.104

7.  National Trends in Direct Health Care Expenditures Among US Adults With Migraine: 2004 to 2013.

Authors:  Amit D Raval; Anal Shah
Journal:  J Pain       Date:  2016-10-24       Impact factor: 5.820

8.  Acupuncture for migraine without aura: a systematic review and meta-analysis.

Authors:  Jia Xu; Fu-Qing Zhang; Jian Pei; Jun Ji
Journal:  J Integr Med       Date:  2018-06-28

9.  Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: A randomized controlled study.

Authors:  Bahram Naderinabi; Alia Saberi; Masood Hashemi; Mohammad Haghighi; Gelareh Biazar; Farid Abolhasan Gharehdaghi; Abbas Sedighinejad; Tahereh Chavoshi
Journal:  Caspian J Intern Med       Date:  2017

Review 10.  Acupuncture for chronic pain: individual patient data meta-analysis.

Authors:  Andrew J Vickers; Angel M Cronin; Alexandra C Maschino; George Lewith; Hugh MacPherson; Nadine E Foster; Karen J Sherman; Claudia M Witt; Klaus Linde
Journal:  Arch Intern Med       Date:  2012-10-22
View more
  4 in total

1.  Comparison of Acupuncture and Sham Acupuncture in Migraine Treatment: An Overview of Systematic Reviews.

Authors:  Mao Li; Weijun Wang; Wen Gao; Dongdong Yang
Journal:  Neurologist       Date:  2022-05-01       Impact factor: 1.524

2.  Acupuncture for Knee Osteoarthritis: A Systematic Review of Randomized Clinical Trials with Meta-Analyses and Trial Sequential Analyses.

Authors:  Hao Tian; Liuyang Huang; Mingsheng Sun; Guixing Xu; Jiamei He; Zhuo Zhou; Fengyuan Huang; Yilin Liu; Fanrong Liang
Journal:  Biomed Res Int       Date:  2022-04-21       Impact factor: 3.246

Review 3.  Efficacy of Moxibustion for Primary Osteoporosis: A Trial Sequential Meta-Analysis of Randomized Controlled Trials.

Authors:  Xiang Li; Zihan Yin; Xiao Li; Bingzun Yin; Yixiang Liu; Wenchuan Qi; Fanrong Liang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-27       Impact factor: 2.650

Review 4.  Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.

Authors:  Jianian Hu; Chong Sun; Jiahong Lu; Chongbo Zhao; Jie Lin
Journal:  J Neurol       Date:  2021-06-12       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.